Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1997 2
1998 2
1999 2
2000 2
2001 2
2002 2
2003 3
2004 2
2005 5
2006 6
2007 10
2008 5
2009 7
2010 8
2011 11
2012 8
2013 11
2014 13
2015 18
2016 14
2017 15
2018 15
2019 12
2020 9
2021 15
2022 16
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Results by year

Filters applied: . Clear all
Page 1
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, Osborne JR, Iravani A, Koo P, Lindenberg L, Baum RP, Bozkurt MF, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen WJG, Rahbar K, Schoder H, Virgolini I, Bodei L, Fanti S, Haberkorn U, Hermann K. Kratochwil C, et al. Among authors: lassmann m. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2830-2845. doi: 10.1007/s00259-023-06255-8. Epub 2023 May 29. Eur J Nucl Med Mol Imaging. 2023. PMID: 37246997 Free PMC article.
EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT).
Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester HJ, Bodei L, Fanti S, Haberkorn U, Herrmann K. Kratochwil C, et al. Among authors: lassmann m. Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2536-2544. doi: 10.1007/s00259-019-04485-3. Epub 2019 Aug 22. Eur J Nucl Med Mol Imaging. 2019. PMID: 31440799
The Relevance of Dosimetry in Precision Medicine.
Lassmann M, Eberlein U. Lassmann M, et al. J Nucl Med. 2018 Oct;59(10):1494-1499. doi: 10.2967/jnumed.117.206649. Epub 2018 Jul 12. J Nucl Med. 2018. PMID: 30002109 Free article. Review.
Radioiodine dosimetry in advanced thyroid cancer.
Giovanella L, Lassmann M. Giovanella L, et al. Among authors: lassmann m. Q J Nucl Med Mol Imaging. 2019 Sep;63(3):227-228. doi: 10.23736/S1824-4785.19.03209-6. Epub 2019 Jul 22. Q J Nucl Med Mol Imaging. 2019. PMID: 31333007 No abstract available.
Biokinetics and Dosimetry of 177Lu-Pentixather.
Hänscheid H, Schirbel A, Hartrampf P, Kraus S, Werner RA, Einsele H, Wester HJ, Lassmann M, Kortüm M, Buck AK. Hänscheid H, et al. Among authors: lassmann m. J Nucl Med. 2022 May;63(5):754-760. doi: 10.2967/jnumed.121.262295. Epub 2021 Aug 19. J Nucl Med. 2022. PMID: 34413147 Free article.
Dosimetry of [⁶⁸Ga]-labeled compounds.
Eberlein U, Lassmann M. Eberlein U, et al. Among authors: lassmann m. Appl Radiat Isot. 2013 Jun;76:70-4. doi: 10.1016/j.apradiso.2012.06.033. Epub 2012 Jul 20. Appl Radiat Isot. 2013. PMID: 22884623 Review.
Radiation Dosimetry Aspects of (177)Lu.
Lassmann M, Eberlein U. Lassmann M, et al. Curr Radiopharm. 2015;8(2):139-44. doi: 10.2174/1874471008666150313104212. Curr Radiopharm. 2015. PMID: 25771372 Review.
Treatment planning in molecular radiotherapy.
Glatting G, Bardiès M, Lassmann M. Glatting G, et al. Among authors: lassmann m. Z Med Phys. 2013 Dec;23(4):262-9. doi: 10.1016/j.zemedi.2013.03.005. Epub 2013 Apr 15. Z Med Phys. 2013. PMID: 23597414 Free article. Review.
203 results